Final results from IMPROVE: a randomized, controlled, open-label, two-arm, cross-over phase IV study to determine patients’ preference for everolimus in combination with exemestane...

por Decker, Thomas, Söling, Ulrike, Hahn, Antje, Maintz, Christoph, Kurbacher, Christian Martin, Vehling-Kaiser, Ursula, Sent, Dagmar, Klare, Peter, Hagen, Volker, Chiabudini, Marco, Falkenstein, Julia, Indorf, Martin, Runkel, Eva, Potthoff, Karin
Publicado 2020